BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2026 12:16:57 PM | Browse: 1 | Download: 0
 |
Received |
|
2025-10-24 07:39 |
|
Peer-Review Started |
|
2025-10-24 07:39 |
|
First Decision by Editorial Office Director |
|
2025-11-18 05:18 |
|
Return for Revision |
|
2025-11-18 05:18 |
|
Revised |
|
2025-11-28 09:56 |
|
Publication Fee Transferred |
|
2025-12-02 00:56 |
|
Second Decision by Editor |
|
2026-01-12 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-12 06:27 |
|
Articles in Press |
|
2026-01-12 06:27 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-18 02:04 |
|
Publish the Manuscript Online |
|
2026-03-27 12:16 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Impact of indomethacin combined with pancreatic duct stent placement on high-risk populations of pancreatitis after endoscopic retrograde cholangiopancreatography
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kai Xu, Dong-Hai Zhou, Jing-Shan Liu and Jian Feng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kai Xu, MD, PhD, Department of General Surgery, Peking University Shougang Hospital, No. 9 Jinyuangzhuang Road, Beijing 100041, China. xking55555@163.com |
| Key Words |
Post-operative pancreatitis; Endoscopic retrograde cholangiopancreatography; Pancreatic duct stent; Indomethacin |
| Core Tip |
This study demonstrates that combining indomethacin suppositories with pancreatic duct stent placement significantly reduces postoperative inflammatory markers (interleukin-6, interleukin-10, C-reactive protein) and improves immune function (higher CD4+/CD8+ ratio) in high-risk post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) patients. The dual intervention also shortens pain relief time and hospital stays compared to monotherapy, offering a synergistic strategy to mitigate PEP-related complications. Key findings highlight its superiority in modulating inflammation and enhancing recovery without increasing severe PEP incidence. |
| Publish Date |
2026-03-27 12:16 |
| Citation |
Xu K, Zhou DH, Liu JS, Feng J. Impact of indomethacin combined with pancreatic duct stent placement on high-risk populations of pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastrointest Surg 2026; 18(3): 115383 |
| URL |
https://www.wjgnet.com/1948-9366/full/v18/i3/115383.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v18.i3.115383 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
